{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:58:38Z","timestamp":1777485518012,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02632-x","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:26:30Z","timestamp":1739460390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unexpected\u00a0HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study"],"prefix":"10.1186","volume":"22","clinical-trial-number":[{"clinical-trial-number":"chictr2100054116","registry":"10.18810\/chictr"}],"author":[{"given":"Qiao","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunling","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingli","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"issue":"1","key":"2632_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mcna.2013.08.004","volume":"98","author":"BJ McMahon","year":"2014","unstructured":"McMahon BJ. Chronic hepatitis B virus infection. Med Clin North Am. 2014;98(1):39\u201354. https:\/\/doi.org\/10.1016\/j.mcna.2013.08.004.","journal-title":"Med Clin North Am"},{"key":"2632_CR2","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. https:\/\/www.who.int\/hepatitis\/strategy2016\u20132021\/ghss-hep\/en\/. Published June 2016. Accessed Aug 2023."},{"issue":"4","key":"2632_CR3","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399. https:\/\/doi.org\/10.1002\/hep.29800.","journal-title":"Hepatology"},{"key":"2632_CR4","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"2632_CR5","unstructured":"Chinese Society of Infectious Diseases CMA, Chinese society of hepatology CMA. [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)]. Zhonghua Gan Zang Bing Za Zhi. 2019;27(12):938\u201361."},{"issue":"1","key":"2632_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2015","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HLY, Chen CJ, et al. Asian-pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hep Intl. 2015;10(1):1\u201398. https:\/\/doi.org\/10.1007\/s12072-015-9675-4.","journal-title":"Hep Intl"},{"key":"2632_CR7","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.14218\/jcth.2022.00047","volume":"10","author":"Z Liu","year":"2022","unstructured":"Liu Z, Chen Z, Cui F, Ding Y, Gao Y, Han G, et al. Management algorithm for prevention of mother-to-child transmission of hepatitis B virus. J Clin Trans Hepatol. 2022;10:1004\u201310. https:\/\/doi.org\/10.14218\/jcth.2022.00047.","journal-title":"J Clin Trans Hepatol."},{"issue":"24","key":"2632_CR8","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"374","author":"CQ Pan","year":"2016","unstructured":"Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1508660.","journal-title":"N Engl J Med"},{"issue":"11","key":"2632_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/jvh.12212","volume":"21","author":"A Ayres","year":"2014","unstructured":"Ayres A, Yuen L, Jackson KM, Manoharan S, Glass A, Maley M, et al. Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations. J Viral Hepatitis. 2014;21(11):809\u201317. https:\/\/doi.org\/10.1111\/jvh.12212.","journal-title":"J Viral Hepatitis"},{"key":"2632_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13036","author":"J Song","year":"2018","unstructured":"Song J, Yang F, Wang S, Tikande S, Deng Y, Tang W, et al. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: a meta-analysis. J Viral Hepatitis. 2018. https:\/\/doi.org\/10.1111\/jvh.13036.","journal-title":"J Viral Hepatitis"},{"issue":"11","key":"2632_CR11","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1136\/gutjnl-2014-308211","volume":"64","author":"M Giles","year":"2015","unstructured":"Giles M, Visvanathan K, Lewin S, Bowden S, Locarnini S, Spelman T, et al. Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B. Gut. 2015;64(11):1810\u20135. https:\/\/doi.org\/10.1136\/gutjnl-2014-308211.","journal-title":"Gut"},{"issue":"4","key":"2632_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/s2468-1253(19)30344-9","volume":"5","author":"MG Ghany","year":"2020","unstructured":"Ghany MG, Feld JJ, Chang K-M, Chan HLY, Lok ASF, Visvanathan K, et al. Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad. Lancet Gastroenterol Hepatol. 2020;5(4):406\u201317. https:\/\/doi.org\/10.1016\/s2468-1253(19)30344-9.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2632_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1031291","author":"X Wang","year":"2022","unstructured":"Wang X, Song A, Lin X, Lu J, Zheng S, Ma L, et al. Clinical characteristics of hepatitis flares during pregnancy and postpartum in Chinese chronic hepatitis B virus carriers\u2014a prospective cohort study of 417 cases. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.1031291.","journal-title":"Front Immunol"},{"key":"2632_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1055774","author":"C-R Wang","year":"2022","unstructured":"Wang C-R, Liu X-q, Li H, Zhang Q, Zhong G-C, Tang Q, et al. PgRNA kinetics predict HBsAg reduction in pregnant chronic hepatitis B carriers after treatment cessation. Front Cell Infect Microbiol. 2022. https:\/\/doi.org\/10.3389\/fcimb.2022.1055774.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"2632_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41395-018-0010-2","volume":"113","author":"W Yi","year":"2018","unstructured":"Yi W, Pan CQ, Li M-H, Wan G, Lv Y-W, Liu M, et al. The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B. Am J Gastroenterol. 2018;113(5):686\u201393. https:\/\/doi.org\/10.1038\/s41395-018-0010-2.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2632_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12072-008-9063-4","volume":"2","author":"H-H Tan","year":"2008","unstructured":"Tan H-H, Lui H-F, Chow W-C. Chronic hepatitis B virus (HBV) infection in pregnancy. Hep Intl. 2008;2(3):370\u20135. https:\/\/doi.org\/10.1007\/s12072-008-9063-4.","journal-title":"Hep Intl"},{"key":"2632_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1112234","author":"L Zhang","year":"2023","unstructured":"Zhang L, Jiang T, Yang Y, Deng W, Lu H, Wang S, et al. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2022.1112234.","journal-title":"Front Immunol"},{"key":"2632_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101050","author":"Y Chen","year":"2024","unstructured":"Chen Y, Mak L-Y, Tang MHY, Yang J, Chow CB, Tan A-M, et al. Immediate postpartum cessation of tenofovir did not increase risk of virological or clinical relapse in highly viremic pregnant mothers with chronic hepatitis B infection. JHEP Report. 2024. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101050.","journal-title":"JHEP Report"},{"issue":"6","key":"2632_CR19","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1111\/liv.12753","volume":"35","author":"J Lu","year":"2015","unstructured":"Lu J, Zhang S, Liu Y, Du X, Ren S, Zhang H, et al. Effect of Peg-interferon \u03b1-2a combined with Adefovir in HBV postpartum women with normal levels of ALT and high levels of HBV DNA. Liver Int. 2015;35(6):1692\u20139. https:\/\/doi.org\/10.1111\/liv.12753.","journal-title":"Liver Int"},{"issue":"1","key":"2632_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.14218\/JCTH.2017.00072","volume":"6","author":"P Hu","year":"2018","unstructured":"Hu P, Shang J, Zhang W, Gong G, Li Y, Chen X, et al. HBsAg loss with peg-interferon Alfa-2a in hepatitis B patients with partial response to nucleos(t)ide analog: new switch study. J Clin Transl Hepatol. 2018;6(1):25\u201334. https:\/\/doi.org\/10.14218\/JCTH.2017.00072.","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"2632_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jhep.2014.05.044","volume":"61","author":"Q Ning","year":"2014","unstructured":"Ning Q, Han M, Sun Y, Jiang J, Tan D, Hou J, et al. Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: a randomised open-label trial (OSST trial). J Hepatol. 2014;61(4):777\u201384. https:\/\/doi.org\/10.1016\/j.jhep.2014.05.044.","journal-title":"J Hepatol"},{"issue":"13","key":"2632_CR22","doi-asserted-by":"publisher","first-page":"881321","DOI":"10.3389\/fimmu.2022.881321","volume":"14","author":"A Song","year":"2022","unstructured":"Song A, Liu Y, Cao Z, Lu J, Ren S, Zheng S, et al. Clinical features and T cell immune characteristics of postpartum hepatitis flare in pregnant women With HBeAg-positive chronic HBV infection. Front Immunol. 2022;14(13):881321. https:\/\/doi.org\/10.3389\/fimmu.2022.881321.","journal-title":"Front Immunol"},{"issue":"2","key":"2632_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/hep4.1460","volume":"4","author":"SS Joshi","year":"2020","unstructured":"Joshi SS, Coffin CS. Hepatitis B and pregnancy: virologic and immunologic characteristics. Hepatol Commun. 2020;4(2):157\u201371. https:\/\/doi.org\/10.1002\/hep4.1460.","journal-title":"Hepatol Commun"},{"issue":"5","key":"2632_CR24","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1053\/j.gastro.2014.01.044","volume":"146","author":"HLY Chan","year":"2014","unstructured":"Chan HLY, Chan CK, Hui AJ, Chan S, Poordad F, Chang T-T, et al. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B Virus DNA. Gastroenterology. 2014;146(5):1240\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2014.01.044.","journal-title":"Gastroenterology"},{"issue":"8","key":"2632_CR25","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1136\/gutjnl-2013-305517","volume":"63","author":"G-A Kim","year":"2014","unstructured":"Kim G-A, Lim Y-S, An J, Lee D, Shim JH, Kim KM, et al. HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability. Gut. 2014;63(8):1325\u201332. https:\/\/doi.org\/10.1136\/gutjnl-2013-305517.","journal-title":"Gut"},{"issue":"4","key":"2632_CR26","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1053\/j.gastro.2011.06.036","volume":"141","author":"CF Chen","year":"2011","unstructured":"Chen CF, Lee WC, Yang HI, Chang HC, Jen CL, Iloeje UH, et al. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology. 2011;141(4):1240-8.e2. https:\/\/doi.org\/10.1053\/j.gastro.2011.06.036.","journal-title":"Gastroenterology"},{"issue":"1","key":"2632_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295(1):65\u201373. https:\/\/doi.org\/10.1001\/jama.295.1.65.","journal-title":"JAMA"},{"key":"2632_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00894.x","author":"MJ ter Borg","year":"2007","unstructured":"ter Borg MJ, Leemans WF, de Man RA, Janssen HLA. Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepatitis. 2007. https:\/\/doi.org\/10.1111\/j.1365-2893.2007.00894.x.","journal-title":"J Viral Hepatitis"},{"issue":"10","key":"2632_CR29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/ajg.2016.296","volume":"111","author":"CY Chang","year":"2016","unstructured":"Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau D, et al. Serum alanine aminotransferase and hepatitis B DNA flares in pregnant and postpartum women with chronic hepatitis B. Am J Gastroenterol. 2016;111(10):1410\u20135. https:\/\/doi.org\/10.1038\/ajg.2016.296.","journal-title":"Am J Gastroenterol"},{"key":"2632_CR30","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.14309\/ajg.0000000000000221","volume":"114","author":"NH Bzowej","year":"2019","unstructured":"Bzowej NH, Tran TT, Li R, Belle SH, Smith CI, Khalili M, et al. Total alanine aminotransferase (ALT) flares in pregnant north american women with chronic hepatitis B infection: results from a prospective observational study. Am J Gastroenterol. 2019;114:1283\u201391. https:\/\/doi.org\/10.14309\/ajg.0000000000000221.","journal-title":"Am J Gastroenterol."}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02632-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02632-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02632-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:26:40Z","timestamp":1739460400000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02632-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2632"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02632-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review 2 Board of the Second Affiliated Hospital of Chongqing Medical University and was registered with the Chinese Clinical Trial Registry (ChiCTR2100054116). The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki. Obtained informed consent forms signed by all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained informed consent forms for publication for all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}